The intestinal epithelium tuft cells: specification and function
This is the type of fat that contributes most severely to things like diabetes, heart disease, and stroke.10 Yet tesamorelin appears to target it specifically
Depre C, Antalik L, Starling A, Koren M, Eisele O, Lenz RA, Mikol DD
Potential benefits include: Improved insulin sensitivity Increased metabolic flexibility Enhanced exercise endurance Better glucose regulation By optimizing cellular energy production, MOTS-C helps create an environment where fat loss becomes more achievable and sustainable
Faster escalation (8-week to 2.4mg) Accelerated titration: Weeks 1-2: 0.6mg weekly Weeks 3-4: 1.2mg weekly Weeks 5-6: 1.8mg weekly Week 7+: 2.4mg weekly Who can attempt: No significant nausea on GLP-1s previously Generally strong GI tolerance Motivated for rapid weight loss Willing to accept higher side effect risk Can reduce dose if needed Expected experience: More pronounced nausea (weeks 3-5 especially) Faster adaptation curve Quicker weight loss onset Reaches maximum efficacy 4+ weeks sooner Success factors: Aggressive nausea management from start Ginger, B6, anti-nausea meds ready Small meal prep planned Ready to slow down if needed Higher maintenance doses (3.0-4.5mg) Rationale: Trials showed 3.0mg and 4.5mg produce slightly more weight loss Some individuals tolerate well Investigational approach 3.0mg weekly: ~11% average weight loss Moderate increase in side effects Reasonable middle ground Some find optimal here 4.5mg weekly: ~12% average weight loss (maximum) Significantly worse nausea/vomiting High dropout rate Not recommended routinely Only for exceptional tolerators Titration to higher doses: Reach 2.4mg first (standard titration) Stable at 2.4mg for 4-8 weeks Increase to 3.0mg if tolerating perfectly Consider 4.5mg only if 3.0mg easy Risk-benefit analysis: 3.0mg: May be worth it for some (1% extra loss) 4.5mg: Usually not worth it (2% extra loss, major side effects) Cost increases proportionally Individual decision Combination with other peptides for synergy Cagrilintide + Semaglutide (CagriSema): Most studied, proven synergy Both at 2.4mg weekly 15-25% total weight loss See detailed combination protocols below Cagrilintide + CJC-1295/Ipamorelin: Cagrilintide: 2.4mg weekly (fat loss) CJC-1295: 200-300mcg 5x weekly (muscle preservation) Ipamorelin: 200-300mcg 5x weekly (body composition) Preserves muscle during aggressive weight loss Better body composition outcomes Cagrilintide + BPC-157: Cagrilintide: 2.4mg weekly (weight loss) BPC-157: 250-500mcg twice daily (gut health) BPC-157 may help with GI side effects Supports gut during weight loss Complementary mechanisms See our peptide stacks guide , peptide stack calculator , CJC-1295 dosage calculator , Ipamorelin benefits , BPC-157 guide , and BPC-157 dosage calculator
BPC-157 for Different Wound Types The versatility of BPC-157 across wound types stands out as one of its most notable characteristics
